Mitochondrial metabolites: Undercover signalling molecules by Frezza, Christian
 on March 9, 2017http://rsfs.royalsocietypublishing.org/Downloaded from rsfs.royalsocietypublishing.orgReview
Cite this article: Frezza C. 2017 Mitochon-
drial metabolites: undercover signalling
molecules. Interface Focus 7: 20160100.
http://dx.doi.org/10.1098/rsfs.2016.0100
One contribution of 9 to a theme issue
‘Chemical biology approaches to assessing and
modulating mitochondria’.
Subject Areas:
biochemistry, chemical biology,
systems biology
Keywords:
mitochondria, signalling, metabolism
Author for correspondence:
Christian Frezza
e-mail: cf366@mrc-cu.cam.ac.uk& 2017 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.Mitochondrial metabolites: undercover
signalling molecules
Christian Frezza
MRC Cancer Unit, University of Cambridge, Cambridge, UK
CF, 0000-0002-3293-7397
Mitochondria are one ofmost characterizedmetabolic hubs of the cell. Here, cru-
cial biochemical reactions occur andmost of the cellular adenosine triphosphate
(ATP) is produced. In addition, mitochondria act as signalling platforms and
communicatewith the rest of the cell bymodulatingcalciumfluxes, byproducing
free radicals, and by releasing bioactive proteins. It is emerging that mitochon-
drial metabolites can also act as second messengers and can elicit profound
(epi)genetic changes. This review describes the many signalling functions of
mitochondrial metabolites under normal and stress conditions, focusing on
metabolites of the tricarboxylic acid cycle. We provide a new framework for
understanding the roleofmitochondrialmetabolism in cellularpathophysiology.1. Introduction
Mitochondria are intracellular organelles evolved from alpha-proteobacteria
engulfed by the ancestor of the eukaryotic cell 2 billion years ago [1]. Although
themechanisms that initiated this symbiosis are still under investigation, it appears
that this process was driven by syntrophy, i.e. the beneficial exchange of nutrients
between the symbiont, an alpha-proteobacteria, and the host cell, an archeon. In
particular, this partnership started under anoxic conditions, where hydrogen mol-
ecules released by the mitochondrion’s ancestor as by-products of its metabolism
were used as an energy substrate by the hydrogen-dependent archeon [2]. The
interaction became closer and closer, until when the symbionts were engulfed by
the host and became essential partners of the newborn eukaryotic cell. Once
engulfed, mitochondria maintained their key functions but they also transferred
part of their genome to the nucleus of the host cell [1]. This trade-off was con-
venient: indeed, mitochondria provided a whole new set of metabolic reactions
to the host cell and drove the evolution of the nuclear membrane and other intra-
cellular organelles. At the same time, the host provided protection and a constant
food supply to the symbiont [3]. Within this complex relationship, mitochondria
evolved several mechanisms of communication with the host, some of which are
critical for cell homeostasis. For instance, mitochondria became key players in cal-
cium signalling [4], and in regulation of cell death via the release of pro-apoptotic
molecules such as cytochrome c [5] when toxic stimuli damage the cell. Further-
more, mitochondria evolved as the main site of production of free radicals, major
signallingmolecules in the cell [6].More recently, it has becomeclear thatmitochon-
drial metabolites, normally considered asmere intermediary for energy generation,
can act as signalling molecules by promoting regulatory post-translational modifi-
cations on proteins, or via affecting chromatin structure and function [7,8]. This
unexpected role of mitochondrial metabolites is the focus of this review.2. The role of mitochondrial metabolites in the communication
between mitochondria and the cell
Mitochondria coordinate several metabolic pathways producing metabolites
required for cell survival and proliferation. Among these pathways, the
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Figure 1. The metabolic and signalling roles of TCA cycle metabolites. (a) In this panel, the major sources (green arrows) and fates (blue arrows) of TCA cycle
metabolites are indicated. Dotted arrows indicate multi-step reactions, whereas solid lines indicate a single-step reaction. (b) Mitochondrial metabolites are also key
signalling molecules. Some of the most established signalling functions of TCA cycle metabolites are indicated ( purple arrows). ACL, ATP-citrate lyase; ACSS, acetyl-
CoA synthetase; FA, fatty acid; FH, fumarate hydratase; GABA, gamma amino butyric acid; GOT, glutamate oxaloacetate transaminase; GPR91, G-protein-coupled
receptor 91, also known as succinate receptor; Irg1, immunoresponsive 1 homologue, also known as aconitate dehydrogenase; ME, malic enzyme; MPC, mitochon-
drial pyruvate carrier; 2OGDH, 2-oxoglutarate dehydrogenase; 2OGDD, 2-oxoglutarate-dependent dioxygenases; PC, pyruvate carboxylase; PDH, pyruvate
dehydrogenase complex; PN, purine nucleotides; SDH, succinate dehydrogenase.
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Although the TCA cycle is generally acknowledged for its con-
tribution to energymetabolism and generation of nicotinamide
adenine dinucleotide (NADH) to fuel the respiratory chain,
this pathway provides the cell with metabolites with unique
signalling functions. Here, I describe the most important
metabolic nodes within this metabolic hub, focusing on metab-
olites, rather than on enzymes that produce them, and their
involvement in the communication with rest of the cell.
2.1. Acetyl CoA
The TCA cycle is fuelled by the energy-rich intermediate
acetyl-coenzyme A (AcCoA), the activated form of acetate.
AcCoA is at a crossroad of multiple metabolic pathways,
including carbohydrate, lipids and protein metabolism
(figure 1a). AcCoA is generated from the oxidation of
glucose-derived pyruvate via the pyruvate dehydrogenase
complex (PDH), the gatekeeper of carbohydrate metabolism.
AcCoA can also be generated from the oxidation of
even-numbered fatty acids (b-oxidation) and from the degra-
dation of the amino acids leucine, isoleucine and tryptophan.
Finally, recent evidence suggests that under hypoxic con-
ditions [9] and during metabolic stress [10] AcCoA can also
be synthesized from acetate and CoA in an ATP-dependent
reaction catalysed by the enzyme AcCoA synthetase. From
a biosynthetic point of view, AcCoA is the building block
for the biosynthesis of lipids, ketone bodies, amino acids,
and cholesterol (figure 1a). While the biosynthesis of ketone
bodies from AcCoA occurs in the mitochondrial matrix,
fatty acid synthesis requires the active export of ‘AcCoA’
equivalents in the form of citrate into the cytosol. Here, citrate
is converted back to AcCoA and oxaloacetate (OA) by the
enzyme ATP-citrate lyase (ACL) and AcCoA can pro-
ceed toward fatty acid synthesis. Of note, the cytosolic
AcCoA obtained by ACL can also be used for cholesterol
biosynthesis, as part of the mevalonate pathway.Beyond being a metabolic intermediate, AcCoA is an
important signalling molecule within the cell (figure 1b).
Indeed, AcCoA is the substrate for protein lysine acetylation,
a post-translational modification that modulates the activity
of metabolic enzymes and, in the nucleus, of histones
(see [11] for a comprehensive review on acetylation). Interest-
ingly, it has been reported that during cell-cycle progression,
PDH complex translocates from the mitochondria to the
nucleus, where it can synthesize AcCoA [12]. Although
more work is needed to corroborate this important finding,
this work suggests that nuclear PDH could contribute to
the generation of a local pool of AcCoA for the fine tuning
of histone acetylation. For this unanticipated function in cell
physiology, AcCoA has been proposed as a ‘sentinel metab-
olite’: while high nucleo-cytosolic levels of this metabolite
are signals for growth and promotes its utilization for lipid
synthesis and histone acetylation, under starvation AcCoA
is preferentially diverted towards the mitochondria to pro-
mote mitochondria-dependent activities such as the
synthesis of ATP and ketone bodies [13].
2.2. Citrate
The condensation of AcCoAwith OA to citrate is catalysed by
the enzyme citrate synthase and represents the first com-
mitted step of the TCA cycle (figure 1a). As indicated
above, mitochondrial citrate can be exported in the cytosol,
where it can be used as source of AcCoA, making citrate
a key lipogenic molecule. Citrate is also an important allo-
steric regulator of central carbon metabolism [14]. When
accumulated, citrate blocks the glycolytic enzyme phospho-
fructokinase (PFK1), the rate-limiting step of glycolysis.
Citrate can also inhibit PFK2, a 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase bi-functional enzyme that inter-
converts fructose-6-phosphate in fructose-2,6-bisphosphate,
a powerful allosteric activator of PFK1 [15] (figure 1b). Fur-
thermore, citrate dampens the activity of the TCA cycle by
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Ultimately, citrate activates AcCoA carboxylase, the first
committed step of fatty acid synthesis, and inhibits the mito-
chondrial transport of fatty acids catalysed by carnitine
palmitoyltransferase 1. Hence, the accumulation of citrate is
an important signal for the cell and leads to the inhibition
of catabolic reactions (glycolysis, fatty acid oxidation and
TCA cycle), favouring anabolism (fatty acid synthesis). It
should also be noted that citrate functions as a chelating
agent and binds physiologically relevant cations such as
Ca2þ, Zn2þ and Mg2þ. Thanks to this role, citrate acts
as a major store of calcium in the bones. Regulating the
availability of these ions might have other important conse-
quences for the bioenergetics of the cells. However, this
property of citrate has not been extensively investigated.
2.3. Cis aconitate/isocitrate
Citrate proceeds in the TCA cycle after conversion to aconitate
and to isocitrate, two sequential reactions catalysed by the
mitochondrial enzyme aconitase 2. Owing to specific kinetic
properties of this enzyme, most cells exhibit a citrate-to-
isocitrate ratio of 10 to 1 [16]. Until recently, it was thought
that the only role of cis-aconitate in mammalian cells was to
serve as a TCA cycle intermediate. However, it was shown
that cis-aconitate can also undergo decarboxylation to
itaconitate through the activity of the enzyme aconitate decar-
boxylase, also known as immune-responsive gene 1 protein
[17]. Although itaconate is a well-known metabolite in
fungi, its role in mammalian pathophysiology has only
recently emerged. For instance, upon lipopolysaccharide
stimulation, itaconate can accumulate in macrophages,
where it exhibits antimicrobial activity [18]. Indeed, itaconi-
tate is a potent inhibitor of isocitrate lyase, a key enzyme of
the glyoxylate cycle, a pathway required for the survival of
many parasitic pathogens. Interestingly, the ability to degrade
itaconate is an important survival strategy for these parasites
[19]. Furthermore, recent work supports the idea that
itaconate can also inhibit SDH [20], but that it harbours
anti-inflammatory effects on macrophages [21].
2.4. 2-Oxoglutarate
Isocitrate is converted to 2-oxoglutarate (2OG) by a group of
NADH (IDH3) and NAPDH-dependent (IDH2/IDH1)
isocitrate dehydrogenase enzymes. 2OG is another con-
vergence point of the TCA cycle. In addition to IDHs, this
metabolite can be generated from glutamine-derived
glutamate by either glutamate dehydrogenase or glutamate-
oxaloacetate aminotransferase (GOT) (figure 1a). Given its
role as an acceptor of nitrogen in various transamination
reactions, 2OG levels probably fluctuate according to the
availability of ammonium.
2OG is the co-substrate of 2OG-dependent dioxygenases
(2OGDD), enzymes involved in several biological processes,
including protein hydroxylation, and DNA and histone
demethylation [22]. These enzymes use 2OG and molecular
oxygen to oxidize their substrate, producing succinate and
carbon dioxide as by-products. Although oxygen has been
considered a major player in the regulation of these enzymes,
it is now emerging that changes in the ratio between succi-
nate and 2OG can also profoundly affect the enzymatic
activity of 2OGDD. Hence, the availability of 2OG represents
an interesting link between mitochondrial function and2OGDD activity. Consistently, it was shown that in naive
embryonic stem cells glutamine-derived 2OG maintains an
elevated 2OG-to-succinate ratio, promoting histone/DNA
demethylation and leading to pluripotency [23]. Further-
more, it was shown that 2OG, by virtue of this epigenetic
function, could also promote early differentiation of mouse
[24] and human [25] pluripotent stem cells. Finally, via regu-
lation of another type of 2OGDD, the prolyl-4-hydroxylase,
2OG is involved in the generation of 4-hydroxyproline and
subsequent collagen maturation, thus affecting extracellular
matrix composition [26] (figure 1b).
It has been demonstrated recently that 2OG can also con-
trol mitochondrial function. Using an elegant approach to
identify targets of this metabolite, Chin and co-workers
found that 2OG binds to and inhibits ATP Synthase leading
to reduced ATP content and decreased oxygen consumption
in both Caenorhabditis elegans and mammalian cells
(figure 1b). Via this mechanisms, 2OG was shown to regulate
the lifespan of C. elegans [27]. Although some criticisms exist
on the concentration of 2OG used in this study, which could
lead to off-target effects, these results strongly suggest that
this metabolite plays a central role in mitochondrial signalling.
2.5. Succinyl-CoA
2OG is converted to succinyl-CoA (SuccCoA) via the enzyme
2OG dehydrogenase (2OGDH). SuccCoA is at a crossroad
of multiple pathways. Besides being the product of 2OG
oxidation, it conveys carbons from the catabolism of odd-
numbered fatty acids, and from the degradation of amino
acids. Furthermore, SuccCoA reacts with glycine in the first
step of haem biosynthesis, a pathway required for the
proper function of iron sulfur cluster proteins and for
oxygen transport (figure 1a).
Besides its role in metabolism, SuccCoA is an important
signalling molecule. Indeed, SuccCoA contributes to protein
lysine succinylation, a recently discovered post-translational
modification [28] (figure 1b). Of note, this modification is
reversible and several efforts have been made to identify
the enzymes involved in its removal. Recently, it was found
that both sirtuin 5 [29,30] and sirtuin 7 [31], members of
the NADþ-dependent class III histone deacetylases sirtuin
family, catalyse protein lysine de-succinylation. The
consequences of succinylation on protein function are still
unclear, but the process is widespread and appears to overlap
acetylation. Interestingly, the identification of succinylated
histones indicates that this modification could also affect
the cell’s epigenome [32], expanding the possible mechan-
isms through which mitochondrial metabolites could
perturb chromatin structure and function.
2.6. Succinate
SuccCoA is converted to succinate via succinyl-CoA thiokinase.
Succinate is also produced from succinic semialdehyde through
the enzyme succinate semialdehyde dehydrogenase, an inter-
mediate reaction of the GABA shunt (figure 1a). This pathway
channels glutamate into the TCA cycle bypassing 2OGDH in
conditions when 2OGDH is impaired, such as under oxidative
stress. Succinate is converted to fumarate by the TCA cycle
enzyme SDH, a key component of the respiratory chain. SDH
is emerging as an important regulatory node for mitochondrial
function and its mutations have been found to be the leading
cause of some types of hereditary and sporadic cancers [7].
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nate, which can accumulate to millimolar levels in the cells [7].
SDH inactivation and ensuing accumulation of succinate can
also be caused by lack of oxygen. Indeed, low oxygen levels
during ischaemia [33], or during exercise [34], have been
shown to increase succinate levels. Of note, the oxidation of
succinate in conditions of high proton motive force or highly
reduced coenzyme Q, such as those observed in ischaemia,
could lead to reverse electron transport (RET), a major source
of free radicals in the mitochondria [35]. Succinate-driven
RET is responsible for ischaemia reperfusion injury [33] and
plays a key role in macrophage polarization [36].
Accumulation of succinate leads to the inhibition of
2OGDD, with profound genetic and epigenetic consequences
[7] (figure 1b). Seminal work from the Gottlieb laboratory
showed that succinate can inhibit prolyl hydroxylases
(PHDs), a group of 2OGDD involved in the hydroxylation
and subsequent proteasomal degradation of the hypoxia
inducible factors [37]. More recent evidence indicates that
succinate can also inhibit 2OGDD involved in histone and
DNA demethylation [38,39]. Considering the competing
role of 2OG and succinate towards 2OGDD, it would be
interesting to determine how cells balance these two
metabolites to govern the cell’s epigenome.
Succinate can also act as a hormone-like molecule. Indeed,
succinate accumulated in body fluids under various circum-
stances, including inflammation or ischaemia, activates the
succinate receptor GPR91, with important physiological
implications ([40] and reviewed in [41]) (figure 1b). For
instance, the stimulation of succinate receptors in the kidney
leads to the activation of the renin–angiotensin system [42],
whereas in the eyes it leads to the production of vascular epi-
thelial growth factor A to support vascularization during
development or after injury [43]. Together, these results
suggest that succinate has important functions in the cells,
well beyond its role as a TCA cycle intermediate.2.7. Fumarate
Fumarate represents another node of the TCA cycle. Besides
being generated in the mitochondria by SDH, other metabolic
pathways funnel fumarate into the TCA cycle. Indeed, fuma-
rate is a breakdown product of tyrosine metabolism, and it is
produced from the urea and purine nucleotide cycles
(figure 1a). Fumarate is converted to malate by the enzyme
fumarate hydratase (FH). Fumarate can accumulate as a con-
sequence of FH inactivating mutations, as in the genetic
disorder fumaric aciduria (OMIM 606812), and in the heredi-
tary cancer syndrome hereditary leiomyomatosis and renal
cell cancer (OMIM 150800). Here, the loss of FH leads to
the accumulation of millimolar levels of fumarate, causing
profound alterations of mitochondrial function and cell
metabolism [7]. Similar to succinate, the accumulation of
fumarate leads to the inhibition of 2OGDD, including PHDs
and histone and DNA demethylases [38,39] (figure 1b). Via
the inhibition of DNA demethylases, fumarate accumulation
was linked to the hypermethylation and subsequent epigenetic
suppression of a class of antimetastatic micro RNAs, miR-200,
leading to an epithelial-to-mesenchymal transition in epithelial
cells [44]. Furthermore, high levels of fumarate lead to protein
succination, a post-translationalmodification of protein cysteine
residues [45]. Through succination of Keap1, fumarate leads to
the aberrant activation of the antioxidant response mediatedby Nrf2 [46,47]. Finally, fumarate was also shown to affect the
kinase TBK1, leading to the non-canonical activation of NF-kB
signalling [48]. Therefore, similarly to succinate, fumarate
appears to be an important mitochondrial messenger, capable
of eliciting broad genetic and epigenetic reprogramming in
the presence of mitochondrial dysfunction.
2.8. Malate
Malate is generated from fumarate by the enzyme FH. Malate
can also be generated from pyruvate by malic enzymes (ME)
(figure 1a). Malate has a key role in energy homeostasis both
under aerobic and anaerobic conditions. Under normal
oxygen tension, the oxidation of malate to OA provides
reducing equivalents from the cytosol to the mitochondria
through the malate–aspartate shuttle. Under hypoxia,
malate undergoes reduction to fumarate, to sustain the
generation of succinate [33]. Malate is also an important
metabolite in redox homeostasis. Indeed, its conversion to
pyruvate by ME leads to the production of reducing equiva-
lents in the form of NADPH. The regulatory functions of
malate are currently unknown.
2.9. Oxaloacetate
OA is the last metabolite in the TCA cycle, generated from
malate by the enzyme malate dehydrogenase. OA is an
important nitrogen acceptor in transamination reactions
including GOT, which converts OA to aspartate (figure 1a).
Therefore, OA is an important source of aspartate, a building
block for protein and nucleotide biosynthesis [49]. The pool
of OA is also replenished via the carboxylation of pyruvate
through the enzyme pyruvate carboxylase (PC). Although
this enzyme normally converts OA to pyruvate during gluco-
neogenesis, it was shown that it fuels the TCA cycle in
conditions when other major carbon sources, such as gluta-
mine, are depleted [50]. Another reaction that replenishes
OA is the carboxylation of the glycolytic intermediate
phosphoenolpyruvate (PEP) through the enzyme phospho-
enolpyruvate carbokinase (PEPCK). Similar to PC, PEPCK
is involved in the production of PEP from OA during gluco-
neogenesis; however, recent evidence suggests that this
enzyme can also work in the PEP-to-OA direction in cancer
cells [51,52]. Besides its role in central carbon metabolism,
little is known about possible functions of OA as a signalling
molecule. Nevertheless, it is worth noting that OA is an
unstable metabolite and it undergoes spontaneous decarbox-
ylation to pyruvate in aqueous solution [53]. It is therefore
possible that due to its short half-life, OA has not evolved
as an efficient signalling molecule.3. From metabolism to signalling, and back
This brief and TCA cycle-centric overview of mitochondrial
metabolism puts forward the view that mitochondrial metab-
olites have a dual role in the cell: on the one side, they are
involved in energy metabolism (figure 1a); on the other
side, they exhibit important signalling functions (figure 1b).
Interestingly, the enzymes of the metabolic network are regu-
lated by transcriptional changes and post-translational
modifications [54] elicited by the same metabolites they pro-
duce. In this scenario, mitochondrial metabolites can be seen
as an interface between metabolic and signalling networks,
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[55]. Some questions arise, though. One question is to what
extent metabolic and signalling cascades converge, i.e.
whether single metabolites are sufficient to fully recapitulate
the function of signalling cascades. Some lines of evidence
seem to support this hypothesis. The observation that metab-
olites such as fumarate [44] and 2-hydroxy-glutarate (2HG)
[56] are sufficient to drive global epigenetic changes suggests
indeed that metabolites play an important role in dictating
the cell’s phenotype. However, to date no studies have been
performed to comprehensively compare the gene signature
triggered by fumarate, succinate, or 2HG, to the ones elicited
by the specific inhibition of different 2OGDDs. Another
question that remains to be addressed is the dynamics of
metabolic signalling. While free radicals produced by
mitochondria have, in general, a short half-life and their reac-
tivity is restricted to biomolecules within close proximity [57],
it is still unclear how persistent the signal triggered by
metabolites is and it probably depends on the metabolic
perturbation that changes their levels. Indeed, in the presence
of profound metabolic alterations, steady state changes in
metabolites levels are likely persistent and could sustain
long-term phenotypical changes, as observed in FH and
SDH-deficient cells, or in IDH-mutant cells. It would be inter-
esting to investigate how metabolic signalling operates under
transient conditions, or when metabolic changes fluctuate
due to environmental cues. Finally, one question concerns
the evolutionary role of metabolic signalling. It is possible
that this type of signalling represents the echo of an ancestral
mechanism of communication between the mitochondrion
and the host cell, which was eventually backed up by more
complex signalling cascades that stabilized or limited the sig-
nalling thus created. As indicated above, the evolutionarydrive of symbiosis seems to lay on synthrophy, i.e. an
active exchange of nutrients between the ancestor of mito-
chondria and its host. It is possible that besides being used
as energy substrates, some of the metabolites released by
the symbiont harboured regulatory functions and modified
the behaviour of the host cell, cementing their long-distance
relationship. This added feature of metabolic intermediates
would have represented a substantial evolutionary advan-
tage for the endosymbiont. Finally, it is tempting to
speculate that mitochondrial metabolites would act not only
as signals for the nucleus, but also for adjacent mitochondria,
to direct a convergent response inside the cell. Intriguingly,
in prokaryotes, the intercellular communication is achieved
via a mechanism called quorum sensing, whereby signalling
molecules released by the individual cells are used to sense
population size, leading to synchronized behaviour [58].
Whether TCA cycle metabolites can also play a role in mito-
chondrion-to-mitochondrion communication is still an open
question and more refined technologies have to be developed
to achieve the spatio-temporal resolution to investigate the
exchange of metabolites between mitochondria.
Overall, the last decade revealed the unexpected role of
mitochondria as key signalling platforms in the cell. Under-
standing how this signalling machinery operates in the cell
and its role in pathophysiological conditions will be the
challenge of the next decade.Competing interests. The author declares no competing interests.
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